Latest News & Features
Americas
The Transatlantic Trade and Investment Partnership has the potential to reinforce intellectual property as a driver of innovation, said Washington, DC-based former lawyer Jennifer Hillman at the BIO International Convention on Tuesday. 17 June 2015
Americas
Jacqueline Wright Bonilla, an administrative judge at the US Patent and Trademark Office, has told the BIO International Convention that despite inter partes review proceedings appearing to favour petitioners, the USPTO is not pro-petitioner, patent owner or even IPR. 17 June 2015
Americas
MultiLing is a Utah-based patent translation company with clients including IBM, Thermo Fisher Scientific and P&G. LSIPR caught up with the company’s senior vice president of worldwide sales Michael Degn at the BIO International Convention in Philadelphia. 17 June 2015
Americas
A US appeals court has affirmed that a patent covering the method of detecting foetal abnormalities in pregnant mothers is ineligible for protection because it applies to a “natural phenomenon”. 17 June 2015
Americas
This year’s BIO International Convention in Philadelphia went off with a bang on Monday night as hundreds travelled to the kickoff concert to see three of the area’s most successful music acts of the last 50 years. 17 June 2015
Americas
US law firm Blank Rome has hired Paul Zagar as a partner to its intellectual property group. 17 June 2015
Americas
The pharmaceutical and biotechnology industries are in “very good shape” and the so-called patent cliff is “firmly in the rear view mirror”, according to a report by life sciences market research company Evaluate. 16 June 2015
Americas
The antibiotics market could lose out for a decade due to inadequate research and development in the area, according to a report published by UK law firm Marks & Clerk today, June 16. 16 June 2015
Americas
US law firm White and Williams has hired George Xixis as a counsel to its Boston office. 12 June 2015
Asia-Pacific
The High Court of Australia has revealed it will hear oral arguments in the patent dispute between breast cancer survivor Yvonne D’Arcy and molecular diagnostic company Myriad Genetics on June 16 and 17. 11 June 2015